/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. Research To Practice | Oncology Videos
  2. Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney
Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Research To Practice | Oncology Videos · Oct 10, 2026

Dr. Sara Tolaney highlights novel ADCs, bispecifics, brain met strategies, and proactive toxicity management in metastatic TNBC treatment.

Avoid Prophylactic Loperamide with Sacituzumab Govitecan to Prevent Severe Constipation

Studies demonstrated that prophylactic loperamide led to severe constipation during sacituzumab govitecan treatment. Dr. Tolaney advises reserving loperamide strictly for as-needed use, while prioritizing growth factor prophylaxis on days two through four and day eight for patients at high risk of neutropenia.

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney thumbnail

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Research To Practice | Oncology Videos·a month ago

Verify Steroid Rinse Adherence Before Reducing Dato-DXD Dosing for Stomatitis

Managing stomatitis caused by datopotamab deruxtecan requires first assessing whether patients used their prophylactic steroid mouth rinse. Noncompliant patients resolve symptoms quickly once the rinse is initiated, whereas persistent stomatitis despite high compliance requires treatment pauses and subsequent dose reductions.

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney thumbnail

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Research To Practice | Oncology Videos·a month ago

Extracranial ADC Efficacy Extends to Intracranial Metastases in Triple-Negative Breast Cancer

Triple-negative breast cancer brain metastases frequently present alongside aggressive visceral disease, making pauses for local brain therapy challenging. Emerging trial data indicate topoisomerase-1-directed ADCs penetrate the central nervous system effectively, showing prolonged activity in both parenchymal brain metastases and leptomeningeal disease.

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney thumbnail

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Research To Practice | Oncology Videos·a month ago

VEGF and PD-L1 Bispecifics Overcome Immunotherapy Resistance in PD-L1-Negative Breast Cancer

Bispecific antibodies targeting VEGF alongside PD-1 or PD-L1 combined with taxanes achieved 70% to 80% response rates in triple-negative breast cancer. Notably, these combinations demonstrated robust efficacy in PD-L1-negative patients, suggesting bispecific construct synergy overcomes VEGF-driven immunosuppression.

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney thumbnail

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 4 with Dr Sara M Tolaney

Research To Practice | Oncology Videos·a month ago